(324 days)
Not Found
No
The description focuses on the sensor's function as a transducer for light signals and does not mention any AI/ML processing of the data. The analysis and display of patient information are attributed to the oximeter system, not the sensor itself.
No.
The device is an accessory (sensor) to an oximeter system that measures and displays arterial oxygen saturation and pulse rate, which are diagnostic measurements for monitoring a patient's condition rather than directly treating a disease or condition.
Yes
Explanation: The device is a transducer/accessory sensor that acquires patient data (functional oxygen saturation and pulse rate) which is then used by an oximeter for analysis and display of patient information. This process aids in monitoring potentially abnormal pulmonary/circulatory function, which is a diagnostic purpose.
No
The device description explicitly states it is an "accessory device to an oximeter monitoring system" and contains "three optical components: two light emitting diodes (LEDs) and one photodiode" within a "laminated envelope with an adhesive bandage" and a "sensor cable". These are all physical hardware components, not software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device function: The description clearly states that the Oxisensor is a non-invasive device that attaches to the patient's digit or foot. It uses light to measure oxygen saturation and pulse rate directly from the patient's body. It does not analyze samples taken from the body.
- Intended Use: The intended use describes monitoring physiological parameters (oxygen saturation and pulse rate) in living patients, not analyzing biological samples.
Therefore, the ClearMedical/Nellcor N-25 Oxisensor is a non-invasive physiological monitoring device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The neonatal/adult Oxisensor, model N-25, is Indicated for single patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for patients weighing less than 3 kg or more than 40 kg.
Product codes
NLF
Device Description
The ClearMedical/Nellcor Oxisensor is an accessory device to an oximeter monitoring system. The oximeter system is designed for the determination of functional oxygen saturation and pulse rate. The oxisensor is designed as a transducer for the transmission of electrical signals from the oximeter to the patient and the return of patient modified signals back to the oximeter for analysis and display of patient information.
The sensor contains three optical components: two light emitting diodes (LEDs) that serve as light sources and one photodiode that acts as a light detector. Both the LEDs and photodiode are contained within a laminated envelope with an adhesive bandage for attachment to a patient. Attached to the laminated envelope is a sensor cable, which terminates in a connector element that connects to the oximeter.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
patients weighing less than 3 kg or more than 40 kg.
Intended User / Care Setting
hospital environment
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Based on an assessment of bench tests and clinical and/or non-clinical performance data, we believe that in all relevant safety and performance indicators the ClearMedical/Nellcor Oxisensor demonstrates substantial equivalence to the Nellcor Oxisensor predicate devices.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows the seal for the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an image of an eagle with three lines representing its wings.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
1 2004 NOV
Clear Medical, Inc. c/o Wayne Pong Quality Team Leader 1776 136th Place NE Bellevue, WA 98005
Re: K012609 - Supplemental Validation Submission Trade/Device Name: See Enclosed List Regulation Number: 21 CFR 870.2700 Regulation Name: Oximeter Regulatory Class: Class II Product Code: NLF Dated: August 8, 2001 Received: August 13, 2001
Dear Mr. Pong:
The above-referenced premarket notification (510(k)) was cleared by the Office of Device Evaluation (ODE) on July 3, 2002. We have received your supplemental validation data as required for reprocessed single-use devices by the Medical Device User Fee and Modernization Act of 2002. After reviewing your supplemental validation data, we have determined the devices listed in the enclosure accompanying this letter are substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market these devices, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your devices are classified (see above) into either class II (Special Controls) or class III (PMA) they may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your devices in the Federal Register.
1
Page 2 - Mr. Wayne Pong
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your devices comply with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's applicable requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
The FDA finding of substantial equivalence of your devices to legally marketed predicate devices results in classification for your devices and thus, permits you to legally market the devices. This letter will allow you to continue marketing the devices listed in the enclosure accompanying this letter.
If you desire specific advice for your devices on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
Qve
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Statement of Indications for Use
510(K) NUMBER (IF KNOWN): __________________________________________________________________________________________________________________________________________________
ClearMedical/Nellcor Oxisensor II, · DEVICE NAME:
Neonatal/Adult O2 Transducer, Part No. N-25
INDICATIONS FOR USE:
The neonatal/adult Oxisensor, model N-25, is Indicated for single patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for patients weighing less than 3 kg or more than 40 kg.
(Please do not write below this line-continue on another page if needed) Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use ] (Per 21 CFR 801.109)
OR Over-The-Counter-Use__
Orvision Sign-C T vision of Dental, Infection Control, Coneral Hospital Devi KO12609 ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
ರಿ
-
- = + = =
3
K012649 - Trade/Bevice Name List
- 8,3
:
1 2019 14:00
一、大学生育学校 学生了教学学
েখ
ﺔ ﺍﻟﻤﻮﺍﻗﻊ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤ
Clear Medical/Nellcor Oxisensor II, Neonatal/Adult O2 Transducer, Model N-25
And And Production
:
4
3 2002 JUL
510(k) Summary K 012609
| Submitter's name and Address: | ClearMedical, Inc.
1776 - 136th Place NE
Bellevue, WA 98005
Ph (425) 401-1414
Fax (425) 401-1515 |
|-------------------------------|--------------------------------------------------------------------------------------------------------------|
| FDA Registration Number: | 3017110 |
| Contact Person: | Richard Radford
Director of Research and Product Development |
| Date Summary Prepared: | August 8, 2001 |
| Trade or Proprietary Name: | ClearMedical/Nellcor Oxisensor II,
Neonatal/Adult O2 Transducer, Part N-25 |
| Common Name: | Oxisensor |
| Classification: | Oximeter (per 21 CFR 870.2700) / DQA |
Equivalent Device
The reprocessed ClearMedical/Nellcor Oxisensor II, Neonatal/Adult O₂ Transducer, Part N-25, is substantially equivalent to the Nellcor Oxisensor II™ Neonatal/Adult O2 , Part N-25 This determination has been reached based on an evaluation and analysis of the predicate device's technical and promotional labeling and specific bench and non-invasive clinical testing. For all established indicators of substantial equivalence, the ClearMedical devices demonstrated equality in safety and performance.
Device Description
The ClearMedical/Nellcor Oxisensor is an accessory device to an oximeter monitoring system. The oximeter system is designed for the determination of functional oxygen saturation and pulse rate. The oxisensor is designed as a transducer for the transmission of electrical signals from the oximeter to the patient and the return of patient modified signals back to the oximeter for analysis and display of patient information.
5
510(k) Summary (Cont'd)
The sensor contains three optical components: two light emitting diodes (LEDs) that serve as light sources and one photodiode that acts as a light detector. Both the LEDs and photodiode are contained within a laminated envelope with an adhesive bandage for attachment to a patient. Attached to the laminated envelope is a sensor cable, which terminates in a connector element that connects to the oximeter.
Intended Use of the Oxisensor
The reprocessed ClearMedical/Nellcor N-25 Oxisensor is intended as a single patient use O₂ transducer/accessory sensor to a Nellcor Oximeter system. The role of the sensor the acquisition of patient data which is used by the oximeter in the determination of functional oxygen saturation and pulse rate of neonatal and adult patients. The N-25 oxisensor is used in conjunction with the Nellcor oximeter in a hospital environment where non-invasive monitoring of pulse oxygen hemoglobin saturation (SpO2) and pulse rate (PR) are required for patients with potentially abnormal pulmonary/circulatory function.
Technological Characteristics of ClearMedical/Nellcor Oxisensor Compared with the Nellcor Oxisensor
The predicate device and the ClearMedical/Nellcor Oxisensor contain three optical components: two light emitting diodes (LEDs) that serve as light sources and one photodiode that acts as a light detector. Both the LEDs and photodiode are contained within a leminated envelope with an adhesive bandage for attachment to a patient, which serves to align the optical sensors and retain the sensor to a patient digit or foot. Attached to the laminated envelope is a sensor cable, which terminates in a molded PVC connector element that connects to the oximeter. In form, the predicate device and the ClearMedical/Nellcor Oxisensor are substantially equivalent.
Other technological indicators of substantial equivalence were identified and included functionality in optical sensitivity of the optical diodes, continuity of sensor numbers comparative non-invasive Co-Oximetry and Oximetry data, infection control methodology, fit/attachment and connector function.
6
Summary of the ClearMedical/Nellcor Oxisensor Performance
Based on an assessment of bench tests and clinical and/or non-clinical performance data, we believe that in all relevant safety and performance indicators the ClearMedical/Nellcor Oxisensor demonstrates substantial equivalence to the Nellcor Oxisensor predicate devices.